Sarissa Capital Management LP's Net Worth

$385 Million

Estimate Recalculated Mar 1, 2024 05:41PM EST

Who is Sarissa Capital Management LP?

Sarissa Capital Management LP has an estimated net worth of $385 Million. This is based on reported shares across multiple companies, which include APRICUS BIOSCIENCES, INC., VIVUS INC, IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., Iterum Therapeutics plc, Regulus Therapeutics Inc., and Innoviva, Inc..

SEC CIK

Sarissa Capital Management LP's CIK is 0001577524

Past Insider Trading and Trends

2023 was Sarissa Capital Management LP's most active year for acquiring shares with 16 total transactions. Sarissa Capital Management LP's most active month to acquire stocks was the month of February. 2021 was Sarissa Capital Management LP's most active year for disposing of shares, totalling 3 transactions. Sarissa Capital Management LP's most active month to dispose stocks was the month of January. 2016 saw Sarissa Capital Management LP paying a total of $7,000,001.36 for 11,931,820 shares, this is the most they've acquired in one year. In 2021 Sarissa Capital Management LP cashed out on 35,619,949 shares for a total of $50,007,284.23, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $14.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.13%
1.35K
120.28K
Dec 15
Form 4
+1.54%
1.8K
118.93K
Sep 15
Form 4
+23.58%
22.35K
117.13K
Jun 20
Form 4
+1.45%
1.36K
94.78K
Jun 15
Form 4
+1.56%
1.44K
93.42K
Mar 15
Form 4
+1.37%
1.24K
91.98K
Dec 15
Form 4
+1.54%
1.37K
90.74K
Sep 15
Form 4
+1.39%
1.22K
89.37K
Jun 15
Form 4
+32.40%
21.57K
88.14K
Jun 1
Form 4
+1.76%
1.15K
66.57K
Mar 15
Form 4
+1.89%
1.21K
65.42K
Dec 15
Form 4
+1.80%
1.14K
64.21K
Sep 15
Form 4
+1.99%
1.23K
63.07K
Jun 15
Form 4
+58.26%
22.77K
61.84K
Jun 2
Form 4
+3.26%
1.24K
39.08K
Mar 15
Form 4
+1.39%
225K
$10.38
$2,335,500.00
16.39M
Mar 8 - Mar 10
Form 4
+5.04%
775K
$10.01
$7,758,750.00
16.16M
Mar 3 - Mar 5
No matching records found

Sarissa Capital Acquisition Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Oct 30
Form 4
0
0
Oct 23
Form 3
0
0
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.7299

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$2.43
-$50,007,284.23
20.62M
Feb 11 - Feb 12
Form 3
0
0
No matching records found

APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.7365

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Mar 21
Form 4
+0.42%
6.1K
$1.63
$9,949.52
1.45M
Aug 31
Form 4
+84.89%
6.65M
$0.88
$5,850,000.64
14.48M
Mar 3
Form 4
+20.03%
1.31M
$0.88
$1,150,000.72
7.83M
Jan 12
Form 3
0
0
No matching records found

Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.3612

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Dec 24
Form 3
0
0
No matching records found